Currently out of the existing stock ratings of Tessa Romero, 53 are a BUY (70.67%), 18 are a HOLD (24%), 4 are a SELL (5.33%).

Tessa Romero

Work Performance Price Targets & Ratings Chart

Analyst Tessa Romero, currently employed at JPMORGAN, carries an average stock price target met ratio of 43.57% that have a potential upside of 28.97% achieved within 99 days.

Tessa Romero’s has documented 145 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 05-Jun-2025.

Wall Street Analyst Tessa Romero

Analyst best performing recommendations are on SRRK (SCHOLAR ROCK HOLDING CORP).
The best stock recommendation documented was for SRRK (SCHOLAR ROCK HOLDING CORP) at 10/3/2024. The price target of $18 was fulfilled within 4 days with a profit of $10.93 (154.6%) receiving and performance score of 386.49.

Average potential price target upside

EWTX Edgewise Therapeutics GBT Global Blood Therapeutics ORTX Orchard Therapeutics PLC ATRA Atara Biotherapeutics RIGL Rigel Pharmaceuticals SRRK Scholar Rock Holding Corp YMAB Y mAbs Therapeutics CYTK Cytokinetics XENE Xenon Pharmaceuticals ACAD ACADIA Pharmaceuticals BHVN Biohaven Pharmaceutical Holding Co Ltd AGIO Agios Pharm DYN Dyne Therapeutics  EYPT Eyepoint Pharmaceuticals MCRB Seres Therapeutics NMRA Neumora Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$43

$27.76 (182.15%)

$45

1 months 18 days ago
(21-Apr-2025)

6/10 (60%)

$29.7 (223.31%)

297

Buy

$51

$35.76 (234.65%)

$51

2 months 6 days ago
(02-Apr-2025)

0/4 (0%)

$35.48 (228.61%)

Buy

$50

$34.76 (228.08%)

$45

5 months 22 days ago
(17-Dec-2024)

0/2 (0%)

$19.83 (65.73%)

Buy

$50

$34.76 (228.08%)

$33

6 months 12 days ago
(27-Nov-2024)

3/4 (75%)

$17.8 (55.28%)

211

Buy

$31

$15.76 (103.41%)

$30

9 months 27 days ago
(12-Aug-2024)

10/10 (100%)

$13.95 (81.82%)

631

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Tessa Romero is most bullish on?

Potential upside of $50.97 has been obtained for BHVN (BIOHAVEN PHARMACEUTICAL HOLDING CO LTD)

Which stock is Tessa Romero is most reserved on?

Potential downside of $2.3 has been obtained for DYN (DYNE THERAPEUTICS )

What Year was the first public recommendation made by Tessa Romero?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?